Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study.
about
A randomized pilot study of atractylenolide I on gastric cancer cachexia patientsCytokines as new treatment targets in chronic heart failureHeart failure in sub-Saharan Africa: review of the aetiology of heart failure and the role of point-of-care biomarker diagnosticsOxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosisNutritional and anti-inflammatory interventions in chronic heart failure.The contribution of South Africans to the subject of dilated cardiomyopathy - with reference to : cardiovascular collagenosis with parietal endocardial thrombosis : a clinicopathologic study of forty cases.Protecting against anthracycline-induced myocardial damage: a review of the most promising strategies.Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy.Reevaluating the role of phosphodiesterase inhibitors in the treatment of cardiovascular disease.Heart failure in 10 years time: focus on pharmacological treatment.Therapeutic inhibition of tumour necrosis factor alpha in patients with heart failure: cooling an inflamed heart.Heart failure and the brain: new perspectives.Vascular endothelium derived endothelin-1 is required for normal heart function after chronic pressure overload in mice.Cachexia in malaria and heart failure: therapeutic considerations in clinical practice.Nutritional strategy in the management of heart failure in adults.Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy.Cardiomyopathy is linked to complement activation.Tumor necrosis factor alpha polymorphism in heart failure/cardiomyopathy.A review of levosimendan in the treatment of heart failure.Future prospects of anticytokine therapy in chronic heart failure.Agents targeting inflammation in heart failure.Immune modulation therapy in heart failure.Anti-tumour necrosis factor-alpha therapy in heart failure: future directions.How can we cure a heart "in flame"? A translational view on inflammation in heart failure.Cardiomyopathies and myocardial disorders in Africa: present status and the way forwardImmunological mechanisms of pentoxifylline in chronic heart failure.Mechanisms for cachexia in heart failure.Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure.Pentoxifylline in heart failure: a meta-analysis of clinical trials.Theobromine Upregulates Osteogenesis by Human Mesenchymal Stem Cells In Vitro and Accelerates Bone Development in Rats.Innate immunity and the failing heart: the cytokine hypothesis revisited.Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases.Role of Inflammation in Heart Failure.Novel Pharmacologic Therapy of Heart Failure.The use of anticoagulation in pediatric cardiac disease.The addition of pentoxifylline to conventional therapy improves outcome in patients with peripartum cardiomyopathy.Pentoxifylline in ischemic, hypertensive and idiopathic-dilated cardiomyopathy: effects on left-ventricular function, inflammatory cytokines and symptoms.Acute myocardial infarction induces hypothalamic cytokine synthesis.Pharmacokinetics of pentoxifylline and its main metabolites in patients with different degrees of heart failure following a single dose of a modified-release formulation.C-reactive protein predicts response to pentoxifylline in patients with idiopathic dilated cardiomyopathy.
P2860
Q24654205-67C34FDB-C328-4AA5-8742-FF876BBAE5E9Q24799394-7EE22F19-592F-417D-8AA5-DD285104751CQ27015261-17628D3A-FB25-4C7B-BE27-B3D9B959133DQ28084150-0B71BE0D-52CF-47DB-90B4-5C297E3879F5Q33880185-DDD6E6A3-4EF8-4104-9A14-DA423BD5EE98Q34357366-5F1C9B71-A766-40B7-8BCC-CCD65B5861B5Q34563378-180BE943-1E74-429D-A0D0-F613BA6A708AQ34632155-EF56A48A-FC35-4756-8B28-CD9812EB4747Q34680320-F8C60E5C-221F-4CF9-BFB1-EC502295EC66Q34817094-8E33757D-E057-4507-8D51-6D5AF657719EQ35026157-6B7DE140-5061-4435-87F7-311633C42AC1Q35046024-8F5BE75E-0D81-4E6F-9D02-939A27ADE24CQ35093746-5CA58FA4-DFFD-4A9D-A272-41DC9CEC670FQ35520657-347726A9-89AB-4996-A5FA-ACE52CF12899Q35631294-31D741A0-FC3A-4CA6-88F5-0DD6FF16F893Q35742297-AA44CEED-447E-41E9-917D-4DDEBAEB2611Q35747543-E4A65914-80D3-4BE8-9FCA-C347287602ACQ35980608-DB687E83-6FFA-451D-8005-3801AF4B3A6FQ36013080-F4A187B8-37FB-475E-AE7B-00D6BD548704Q36087238-C1AA4C35-3007-4A58-9768-839024AF72EDQ36145827-D7C3196D-EFFD-4FE0-AC65-9B134803254EQ36440971-B8CC1681-74A5-4242-97A5-C731846DDAFCQ36684042-2E7D1F66-707E-40C6-8FF5-C3123EEE2B42Q37004826-D0AE76B8-E00C-4151-A6C4-057E1EE7158EQ37041843-DEC428A2-E7C8-4566-A83F-66AE6CF6C6E8Q37377105-3933C8C3-79E3-42AB-B5DD-B90CC7F01AFBQ38127358-9352FC10-DECB-45D2-A9A4-AD652E0CBA87Q38183314-089F9449-1BE7-4661-A7D3-84220F054BE8Q38206557-91ADDFC0-5B61-4029-BC56-2EF2601AB1B7Q38376984-16EAF6EF-8E57-425C-8706-497FA5546A43Q38393039-D0676F0E-951C-4089-B79E-C57CE8B7F058Q38663003-189F0A57-40B3-470D-93F4-8C636C0DCB7BQ39255848-48C283B5-BC9E-43C0-A113-00050E342031Q39393256-1BE21589-9CEE-4776-86A1-98F0234DA44FQ39653469-F45703AB-BA86-4A1D-99AB-F1E43A198D5BQ44008855-E5C574DA-2FAE-4EDD-B071-84E6A5F06E69Q44776909-D39E046E-DB37-4D33-95A2-D269E8113431Q44899575-21664FC0-F9C2-4F26-A1A8-28C3C0FBBB2FQ44972895-D1308B22-753E-48FB-9756-8161277243D6Q45149750-3AA306EF-EE17-4DC5-8D4E-4E1B73FABD69
P2860
Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Beneficial effects of pentoxif ...... results of a randomized study.
@ast
Beneficial effects of pentoxif ...... results of a randomized study.
@en
type
label
Beneficial effects of pentoxif ...... results of a randomized study.
@ast
Beneficial effects of pentoxif ...... results of a randomized study.
@en
prefLabel
Beneficial effects of pentoxif ...... results of a randomized study.
@ast
Beneficial effects of pentoxif ...... results of a randomized study.
@en
P2093
P1433
P1476
Beneficial effects of pentoxif ...... results of a randomized study.
@en
P2093
P304
P356
10.1161/01.CIR.103.8.1083
P407
P577
2001-02-01T00:00:00Z